Leo-shouldn't scripts be a harbinger for sales to come. If sales are increasing so well with a very limited label, an exponential growth will follow an expanded label.
Keep in mind the addition of ~ 3000 scripts seems to be driven by a positive ADCOM vote. This equates to an additional $4.3m in annual sales for this one week alone.
Imagine the impact when it’s actually FDA approved for the indication.
News 
Market Data 
Discover 
